Ven Bio Global Strategic Fund Iii, L.P. Ventyx Biosciences, Inc. (VTYX) insider trading activity

Ven Bio Global Strategic Fund Iii, L.P. is > 10% Shareholder of Ventyx Biosciences, Inc.. Currently has a direct ownership of 4 Million shares of VTYX, which is worth approximately $9.31 Million. The most recent transaction as insider was on Oct 25, 2021, when has been sold 312,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $5,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4M

0% 3M change

0% 12M change

Total Value Held $9.31 Million

venBio Global Strategic Fund III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 25 2021	BUY Open market or private purchase	$5,000,000 $16.0 p/Share	312,500 Added 7.25%	3,997,269 Common Stock
Oct 25 2021	BUY Conversion of derivative security	-	3,684,769 Added 50.0%	3,684,769 Common Stock

Also insider at

ELEV

Elevation Oncology, Inc. Healthcare

RYZB

RayzeBio, Inc.

RTVA

Artiva Biotherapeutics, Inc.

vGS